Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
Primary Purpose
Chronic Kidney Disease Predialysis
Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Combination Exercise
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Kidney Disease Predialysis focused on measuring fatigability, strength, rehabilitation, eccentric exercise, combination exercise
Eligibility Criteria
Inclusion Criteria:
- Ambulatory (with or without a gait aid), 50 years of age or older diagnosed with chronic kidney disease (CKD) stages 3 & 4 predialysis (as defined by eGFR 59-15 ml/min per 1.73m2)
- Control group will include ambulatory individuals without clinical evidence of kidney disease (defined by eGRF >60 ml/min per 1.73m2) within the last 12-months
- All participants must be able to speak and read English, and demonstrate orientation to person, place, and time
Exclusion Criteria:
- adults diagnosed with acute renal failure/injury within the last 12-months
- non-ambulatory individuals
- adults who do not use the DC VAMC as their main site for renal care
- those who have any uncontrolled cardiovascular
- musculoskeletal disease
- or other conditions that, in the opinion of the principal investigator, could make participation in the study unsafe
- any orthopedic or joint pain which would prevent the participant from safely engaging in the study protocol
- additionally, individuals with plans to relocate from the DC metro area within one year will not be eligible for the intervention portion of the study
Sites / Locations
- Washington DC VA Medical Center, Washington, DCRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Combination Exercise
Standard-of-care
Arm Description
Flywheel resistance exercise plus aerobic exercise
Participants will maintain standard-of-care and current activity levels during the course of the study.
Outcomes
Primary Outcome Measures
change in knee extensor fatigability
Knee extensor fatigability will be assessed as changes in torque of the dominant leg during 30 contractions.
change in perceived fatigability
Rating of perceived fatigability will be assessed using a 10-point scale with 0 indicating "not fatigued at all" and 10 indicating "absolutely exhausted". Low scores reflect lower perceived fatigability.
change in muscle blood flow
Muscle blood flow of the vastus lateralis will be assessed using near-infrared spectroscopy and determined as the change in total hemoglobin during venous occlusion test.
Secondary Outcome Measures
change in muscle Quality
Muscle quality of the vastus lateralis will be assessed using diagnostic ultrasound and determined using grayscale analysis.
change in Sit-to-Stand
Sit-to-stand test will be used to assess physical function and determined as the time taken to complete five sit-to-stand repetitions.
change in rate of torque development
Rate of torque development will be calculated as the change in torque over the change in time during isometric knee extensions.
Full Information
NCT ID
NCT04397159
First Posted
May 13, 2020
Last Updated
May 16, 2023
Sponsor
VA Office of Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT04397159
Brief Title
Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
Official Title
Objective and Subjective Measures of Fatigability in Veterans With Chronic Kidney Disease Before and After Flywheel Resistance Plus Aerobic Exercise
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
April 1, 2026 (Anticipated)
Study Completion Date
April 1, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The VA health care system uses a health promotion-focused model which aims to provide longitudinal care through a patient-aligned care team for Veterans with chronic kidney disease. Since the largest subpopulation of Veterans with chronic kidney disease is comprised of those not requiring dialysis, neuromuscular screening assessments may provide valuable information regarding an individual overall health status and potential for future complications. Furthermore, identifying at risk individuals early in the disease process will allow for the prescription of timely interventions. Exercise strategies such as combination exercise, which uses flywheel resistance plus aerobic exercise, may provide a valuable treatment option for combating neuromuscular dysfunction and functional decline in patients with chronic kidney disease.
Detailed Description
Chronic kidney disease (CKD) is a complex medical condition affecting as much as 36% of the Veteran population. Both empirical and anecdotal evidence identify elevations in fatigability as a major health concern in Veterans with CKD predialysis. Neuromuscular deteriorations resulting from CKD are likely to contribute to excessive fatigability, impacting an individual's functional status. Flywheel resistance exercise (FRE) uses inertial resistance to allow for optimal muscle loading through the entire concentric muscle action and promotes greater eccentric force generation compared to traditional resistance exercise. FRE has been shown to be superior to traditional resistance exercise for improving muscle strength, power, and physical function in healthy populations suggesting it may be a useful treatment for addressing neuromuscular impairments and functional decline. However, it is unclear if the addition of aerobic exercise to FRE would provide additive improvements in fatigue resistance in patients with CKD, without compromising neuromuscular and functional benefits. The purpose of this project is to (1) advance the understanding of performance fatigability and perceived fatigability, and the association with neuromuscular capacity in Veterans with CKD stage 3 & 4 predialysis and (2) determine the extent to which combination FRE plus aerobic exercise training can improve fatigability status, neuromuscular capacity, and physical function in Veterans with CKD stage 3 & 4 predialysis. The central hypothesis is that reductions in neuromuscular capacity are associated with increases in fatigability severity, and that FRE plus aerobic exercise training will reduce fatigability severity while enhancing neuromuscular and functional capabilities in Veterans with CKD stage 3 & 4 predialysis. To address this hypothesis, researchers will characterize performance fatigability and perceived fatigability, and assess the associations between fatigability outcomes and neuromuscular capacity in Veterans with CKD stage 3 & 4 predialysis and examine the effects of 12-weeks of FRE plus aerobic exercise training on changes in performance and perceived fatigability, neuromuscular capacity, and physical function in Veterans with CKD stage 3 & 4 predialysis. Findings from this project will provide valuable information for advancing the understanding of performance fatigability and perceived fatigability, and their inter-relationship, in Veterans with CKD stages 3 and 4. Additionally, novel evidence on the responsiveness of performance and perceived fatigability, neuromuscular capacity, and quality of life to FRE plus aerobic exercise training will be gained.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease Predialysis
Keywords
fatigability, strength, rehabilitation, eccentric exercise, combination exercise
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
Flywheel Resistance Plus Aerobic Exercise
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Combination Exercise
Arm Type
Experimental
Arm Description
Flywheel resistance exercise plus aerobic exercise
Arm Title
Standard-of-care
Arm Type
No Intervention
Arm Description
Participants will maintain standard-of-care and current activity levels during the course of the study.
Intervention Type
Behavioral
Intervention Name(s)
Combination Exercise
Other Intervention Name(s)
Flywheel Resistance Plus Aerobic Exercise
Intervention Description
Flywheel Resistance Plus Aerobic Exercise
Primary Outcome Measure Information:
Title
change in knee extensor fatigability
Description
Knee extensor fatigability will be assessed as changes in torque of the dominant leg during 30 contractions.
Time Frame
week 6 and 12
Title
change in perceived fatigability
Description
Rating of perceived fatigability will be assessed using a 10-point scale with 0 indicating "not fatigued at all" and 10 indicating "absolutely exhausted". Low scores reflect lower perceived fatigability.
Time Frame
week 6 and 12
Title
change in muscle blood flow
Description
Muscle blood flow of the vastus lateralis will be assessed using near-infrared spectroscopy and determined as the change in total hemoglobin during venous occlusion test.
Time Frame
week 6 and 12
Secondary Outcome Measure Information:
Title
change in muscle Quality
Description
Muscle quality of the vastus lateralis will be assessed using diagnostic ultrasound and determined using grayscale analysis.
Time Frame
week 12
Title
change in Sit-to-Stand
Description
Sit-to-stand test will be used to assess physical function and determined as the time taken to complete five sit-to-stand repetitions.
Time Frame
week 12
Title
change in rate of torque development
Description
Rate of torque development will be calculated as the change in torque over the change in time during isometric knee extensions.
Time Frame
week 12
Other Pre-specified Outcome Measures:
Title
change in muscle activation
Description
Muscle activation of the vastus lateralis will be determined using electromyography as the root mean square during isometric knee extensions.
Time Frame
week 12
Title
change in interleukin 6 (IL-6) and tumor necrosis factor alpha
Description
Interleukin 6 (IL-6) (pg/ml) and tumor necrosis factor alpha (pg/ml) will be assessed from blood samples.
Time Frame
week 12
Title
change in health-related quality of life
Description
Health-related quality of life will be assessed using the Short-form 36
Time Frame
week 12
Title
change in high density c-reactive protein
Description
Change in high density c-reactive protein (mg/L) will be assessed from blood samples.
Time Frame
week 12
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Ambulatory (with or without a gait aid), 50 years of age or older diagnosed with chronic kidney disease (CKD) stages 3 & 4 predialysis (as defined by eGFR 59-15 ml/min per 1.73m2)
Control group will include ambulatory individuals without clinical evidence of kidney disease (defined by eGRF >60 ml/min per 1.73m2) within the last 12-months
All participants must be able to speak and read English, and demonstrate orientation to person, place, and time
Exclusion Criteria:
adults diagnosed with acute renal failure/injury within the last 12-months
non-ambulatory individuals
adults who do not use the DC VAMC as their main site for renal care
those who have any uncontrolled cardiovascular
musculoskeletal disease
or other conditions that, in the opinion of the principal investigator, could make participation in the study unsafe
any orthopedic or joint pain which would prevent the participant from safely engaging in the study protocol
additionally, individuals with plans to relocate from the DC metro area within one year will not be eligible for the intervention portion of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jared M Gollie, PhD
Phone
(202) 745-8000
Email
Jared.Gollie@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jared M. Gollie, PhD
Organizational Affiliation
Washington DC VA Medical Center, Washington, DC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington DC VA Medical Center, Washington, DC
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422-0001
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jared M Gollie, PhD
Phone
202-745-8000
Email
Jared.Gollie@va.gov
First Name & Middle Initial & Last Name & Degree
Jared M. Gollie, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
We'll reach out to this number within 24 hrs